These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31118604)

  • 1. Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy.
    Du X; Zhang T; Ma G; Gu X; Wang G; Li J
    Int J Nanomedicine; 2019; 14():2233-2251. PubMed ID: 31118604
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-Responsive Sequential Generation of Hydrogen Peroxide and Nitric Oxide for Synergistic Cancer Starving-Like/Gas Therapy.
    Fan W; Lu N; Huang P; Liu Y; Yang Z; Wang S; Yu G; Liu Y; Hu J; He Q; Qu J; Wang T; Chen X
    Angew Chem Int Ed Engl; 2017 Jan; 56(5):1229-1233. PubMed ID: 27936311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
    Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

  • 8. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
    Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
    Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mesoporous silica nanoparticles (MSNs) for highly controllable drug release and synergistic therapy.
    Cheng YJ; Zeng X; Cheng DB; Xu XD; Zhang XZ; Zhuo RX; He F
    Colloids Surf B Biointerfaces; 2016 Sep; 145():217-225. PubMed ID: 27182657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
    Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
    Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
    Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH/H
    Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment.
    Qi G; Shi G; Wang S; Hu H; Zhang Z; Yin Q; Li Z; Hao L
    Int J Nanomedicine; 2023; 18():7133-7147. PubMed ID: 38054080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
    Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
    Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.